Sign Up

TSBX

COM:TURNSTONEBIO

Turnstone Biologics

  • Stock

Last Close

0.47

22/11 21:00

Market Cap

55.51M

Beta: -

Volume Today

151.33K

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
average inventory
382K
-
2.58M
574.48%
average payables
1.73M
-
1.74M
0.23%
average receivables
7.72M
-
4.46M
42.23%
book value per share
-3.69
-
-4.57
23.97%
0.01
100.19%
capex per share
-0.15
-
-0.23
51.79%
-0.00
99.95%
capex to depreciation
-2.45
-
-1.33
45.91%
-0.45
66.32%
capex to operating cash flow
0.07
-
0.07
2.53%
0.02
74.05%
capex to revenue
-0.03
-
-0.07
109.76%
-0.06
8.28%
cash per share
7.26
-
3.70
49.04%
0.01
99.78%
days of inventory on hand
days payables outstanding
days sales outstanding
24.20
-
43.46
79.62%
3.67
91.56%
debt to assets
0.01
-
0.04
213.67%
0.03
36.61%
debt to equity
-0.03
-
-0.05
55.32%
0.03
163.98%
dividend yield
earnings yield
0.14
-
-0.13
192.68%
-0.00
98.52%
enterprise value
123.38M
-
214.51M
73.87%
29.41B
13,611.69%
enterprise value over ebitda
3.59
-
-7.74
315.62%
-523.05
6,660.26%
ev to operating cash flow
-2.70
-
-3.02
11.64%
-444.63
14,629.42%
ev to sales
1.22
-
2.93
140.26%
1.52K
51,959.83%
free cash flow per share
-2.21
-
-3.44
55.46%
-0.01
99.83%
free cash flow yield
-0.20
-
-0.31
55.46%
-0.00
99.27%
graham net net
-4.64
-
-5.75
24.07%
0.01
100.13%
graham number
11.16
-
11.96
7.19%
0.03
99.75%
income quality
-1.37
-
2.30
268.04%
1.20
48.00%
intangibles to total assets
0
-
0
0
interest coverage
interest debt per share
0.12
-
0.23
92.55%
0.00
99.88%
inventory turnover
invested capital
-0.03
-
-0.05
55.32%
0.03
163.98%
market cap
244.08M
-
244.08M
0%
29.43B
11,956.76%
net current asset value
-91.75M
-
-118.40M
29.05%
88.41M
174.66%
net debt to ebitda
-3.51
-
1.07
130.38%
0.26
75.68%
net income per share
1.50
-
-1.39
192.68%
-0.00
99.66%
operating cash flow per share
-2.06
-
-3.20
55.74%
-0.01
99.82%
payables turnover
receivables turnover
15.08
-
8.40
44.33%
99.52
1,084.95%
research and ddevelopement to revenue
0.54
-
1.18
118.82%
3.13
164.89%
return on tangible assets
0.18
-
-0.27
250.99%
-0.49
82.39%
revenue per share
4.57
-
3.30
27.64%
0.00
99.95%
roe
-0.41
-
0.30
174.76%
-0.56
284.10%
roic
-0.43
-
0.35
181.87%
-0.56
260.29%
sales general and administrative to revenue
0.13
-
0.25
85.90%
0.92
271.84%
shareholders equity per share
-3.69
-
-4.57
23.97%
0.01
100.19%
stock based compensation to revenue
0.03
-
0.09
239.60%
0.22
149.37%
tangible asset value
-81.85M
-
-101.47M
23.97%
98.67M
197.24%
tangible book value per share
-3.69
-
-4.57
23.97%
0.01
100.19%
working capital
122.37M
-
63.17M
48.37%
90.58M
43.39%

All numbers in (except ratios and percentages)